The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine

by Mufide Okay MD, Yusuf Ozturk MD, Ibrahim C. Haznedaroglu MD
Published 2019-01-01

TKI-Related Platelet Dysfunction Does Not Correlate With Bleeding in Patients With Chronic Phase-Chronic Myeloid Leukemia With Complete Hematological Response

by Yigit Sener MD, Mufide Okay MD, Seda Aydin MD, Yahya Buyukasik MD, Filiz Akbiyik MD, Zeliha Gunnur Dikmen MD
Published 2019-06-01

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia

by Mehdi Ghasemi, Mufide Okay, Seyhan Turk, Ronak Naeemaee, Ebru Guver, Umit Y Malkan, Salih Aksu, Nilgun Sayinalp, Ibrahim C Haznedaroglu
Published 2019-05-01

Cytogenetic anomalies in Multiple Myeloma patients:A single center study.

by Süreyya Bozkurt, Yahya Büyükaşık, Haluk Demiroğlu, Elifcan Aladağ Karakulak, Müfide Okay, Ayşe Karataş, Salih Aksu, İbrahim Haznedaroğlu, Nilgün Sayınalp, Osman Özcebe, Hakan Göker
Published 2019-06-01

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide.

by Seyhan Turk, Can Turk, Muhammad Waqas Akbar, Baris Kucukkaraduman, Murat Isbilen, Secil Demirkol Canli, Umit Yavuz Malkan, Mufide Okay, Gulberk Ucar, Nilgun Sayinalp, Ibrahim Celalettin Haznedaroglu, Ali Osmay Gure
Published 2020-01-01